What Erectol Plus Treats: Main Uses and Benefits

Erectol Plus is commonly used to help with two primary therapeutic domains, both considered relevant for supportive circulatory management. This medication is applied in addressing symptoms related to Erectile Dysfunction (ED) and Pulmonary Arterial Hypertension (PAH).

In the context of ED, Erectol Plus supports the necessary circulatory response in adult men experiencing difficulty achieving or maintaining a functional erection, a condition that interferes with daily functioning. For PAH, it is commonly used to help manage symptom clusters that may become intense or disruptive, such as chronic shortness of breath and reduced exercise tolerance. The application of this medication offers symptomatic relief that helps patients cope more steadily with difficult episodes and may assist with maintaining functional stability in daily life.

The core benefit is related to providing supportive relief across these two domains. This provides supportive assistance in contexts where additional symptomatic support is needed, helping to ease the overall symptom burden.

Quick Fact: Relief for Impaired Functional Circulation
Primary Therapeutic Use	Management of Erectile Dysfunction (ED) and Pulmonary Arterial Hypertension (PAH).
Targeted Symptoms	Symptom clusters related to impaired erectile function; symptoms of increased physiological stress (shortness of breath, fatigue).
General Benefit	Supports the easing of symptoms that interfere with daily functioning and contributes to improved comfort.

Regulatory References

1. NIH MedlinePlus Drug Information

Who Can and Cannot Use Erectol Plus?

The official eligibility for Erectol Plus (Sildenafil) is strictly defined by regulatory documents, distinguishing between populations who are eligible, those requiring caution, and those for whom use is absolutely contraindicated.

Absolute Contraindications

The medicine must not be used by patients who are concurrently taking any form of organic nitrates or nitric oxide donors, or those using guanylate cyclase stimulators (such as riociguat). Use is also contraindicated in individuals with a known hypersensitivity to Sildenafil, recent stroke or myocardial infarction, severe resting hypotension (BP < 90/50 mmHg), severe hepatic impairment (Child-Pugh Class C), or a history of vision loss due to Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION).

Age and Condition Restrictions

Erectol Plus is approved for use in adults (18 years and older) with Erectile Dysfunction (ED) or Pulmonary Arterial Hypertension (PAH). Pediatric use for chronic PAH is generally not recommended due to specific safety concerns observed at higher doses. Patients with severe renal impairment or mild to moderate hepatic impairment should have a lower starting dose considered for the ED indication. Conditional use is also required for patients predisposed to priapism (e.g., sickle cell disease) or those with anatomical deformation of the penis.

Interactions with other medicines and products

Regulatory agencies have issued warnings regarding products promoted as dietary supplements for sexual enhancement, such as Erectol Plus, due to the presence of undeclared active pharmaceutical ingredients that are potent Phosphodiesterase type 5 inhibitors (PDE5i), like sildenafil or tadalafil.

This hidden drug content creates a major, life-threatening drug interaction with nitrate medications. The combination is strictly contraindicated and must be avoided.

Interacting Product Category	Specific Interacting Agents (Examples)	Interaction Severity
Organic Nitrates	Nitroglycerin, Isosorbide mononitrate/dinitrate	Severe (Contraindicated)
Recreational Nitrates	Amyl nitrate, Butyl nitrate (e.g., “poppers”)	Severe (Contraindicated)
Other PDE5 Inhibitors	Sildenafil, Tadalafil, Vardenafil	Clinically Significant

Interaction Mechanism and Risk: The PDE5 inhibitor in the product, when combined with nitrates, causes a synergistic increase in cyclic Guanosine Monophosphate (cGMP) levels, leading to profound and uncontrolled vasodilation. This results in a precipitous, dangerous drop in blood pressure (hypotension) that can cause fainting, shock, myocardial infarction, or stroke. Individuals with underlying conditions like heart disease, high blood pressure, or diabetes who are prescribed nitrates are at the highest risk.

Timing-Based Restriction: Official guidelines for prescription PDE5 inhibitors mandate a minimum spacing period. Nitrates must not be administered within at least 24 hours of taking sildenafil, or 48 hours if the undeclared ingredient is a longer-acting agent like tadalafil.

The mechanism of Erectol Plus (Sildenafil) is rooted entirely in enhancing a natural, demand-driven physiological signaling cascade. The drug functions not as an initiator but as a potentiator of pre-existing signals that regulate vascular tone.

Targeted Inhibition of the PDE5 Enzyme

The primary molecular mechanism involves the competitive inhibition of the enzyme Phosphodiesterase type 5 (PDE5), which is predominantly located in the vascular smooth muscle cells of specific tissues. By blocking this enzyme, the drug prevents the rapid deactivation of the key chemical messenger, cGMP, which regulates smooth muscle contraction/relaxation cycles.

Potentiating the Nitric Oxide Pathway

This inhibition acts to potentiate the signal initiated by Nitric Oxide (NO), which is released naturally under physiological stimulus. The resulting prolonged and sustained elevation of cGMP directly causes the relaxation of the vascular smooth muscle. This physiological change facilitates a targeted and significant increase in arterial blood inflow to the relevant anatomical regions, which is the expected systemic consequence of the drug's molecular action.

Mechanism Constraints (NO Dependence)

It is critical to note that the drug's mechanism is physiologically constrained; it cannot initiate the smooth muscle relaxation process independently. The entire effect profile is strictly dependent upon the prior, localized release of Nitric Oxide (the natural trigger), meaning the drug's action is mechanistically constrained in the absence of this stimulus.

Erectol Plus, containing sildenafil, is administered through two primary methods: orally, using the tablet or reconstituted suspension, or via intravenous bolus injection. The usage pattern is defined by the condition being addressed.

Usage for Erectile Dysfunction (ED)

For use in Erectile Dysfunction, the medication follows an intermittent, as-needed regimen. The typical starting dose is 50 mg, which can be adjusted downward to 25 mg or upward to a maximum of 100 mg, and is limited to once per day. This dose is usually administered approximately one hour prior to anticipated activity, though the window ranges from 30 minutes to four hours. While the tablets can be taken with or without food, a high-fat meal may delay the rate of absorption. Specific dose modifications are recommended for individuals with severe renal or hepatic impairment, for whom a 25 mg starting dose is typically considered due to reduced clearance.

Usage for Pulmonary Arterial Hypertension (PAH)

In the context of Pulmonary Arterial Hypertension, administration is continuous, requiring a multiple-dose schedule. The standard oral dose is 20 mg, taken three times per day, with doses spaced approximately four to six hours apart. This continuous dose may be titrated up to 80 mg three times a day. For patients temporarily unable to take the oral form, the intravenous route is administered as a 10 mg bolus injection three times daily. If the oral suspension formulation is used, it requires specific preparation, including reconstitution with a determined volume of water, and must be accurately measured using a calibrated device before each administration.

Erectol Plus: Recent Clinical Evidence

Evidence for use in Erectile Dysfunction (ED)

The research base for Sildenafil consists mainly of short-term, randomized, placebo-controlled clinical trials (RCTs). These studies, involving men with ED of varied origins, focused on patient-reported outcomes related to functional capacity, such as the ability to achieve and maintain an erection. Systematic reviews and meta-analyses report the measurements recorded during these study periods. Evidence concerning outcomes in certain patient subgroups or from direct comparative trials against other PDE5 inhibitors remains limited.

Evidence for use in Pulmonary Arterial Hypertension (PAH)

Sildenafil was evaluated in short-term RCTs that examined functional outcomes, such as the Six-Minute Walk Distance (6MWD), and monitored hemodynamic outcomes. Data describe the measured functional changes in patients with PAH. Research also examined findings related to the impact on long-term survival, which have been varied across studies. Official sources note that the collection of definitive evidence on long-term mortality requires further mandated investigation.

Long-Term Studies and Durability of Research

Initial efficacy trials focused on short-term changes; therefore, long-term symptom patterns remain insufficiently characterized through controlled studies. Evidence concerning sustained outcomes over several years consists mainly of data from non-randomized, open-label extension studies.

Evidence in Special Populations

Research has explored outcomes for specific patient subgroups, including adult men with comorbidities like diabetes or those who underwent radical prostatectomy. Research has also examined Sildenafil in pediatric patients with PAH, though data for this group remain insufficient, leading to differing guidance across international regulatory bodies.

Synthesis of Research Gaps and Uncertainties

A key uncertainty is the lack of comparative evidence from head-to-head trials against other PDE5 inhibitor medicines. Furthermore, research exploring the impact on critical long-term outcomes, such as mortality in the adult PAH population, is not fully established and remains an area of mandated ongoing investigation.

Key Studies & References

1. MedlinePlus Drug Information: Sildenafil (Oral Route) - Overview and Uses
2. MedlinePlus Drug Information: Sildenafil (Oral Route) - Mechanism of Action/Pharmacology

Common questions about Erectol Plus (FAQ)

---

Q: Can Erectol Plus be taken by people who are generally healthy?

Official information states the drug is indicated for the treatment of Erectile Dysfunction (ED) or Pulmonary Arterial Hypertension (PAH). The mechanism of action for the ED indication is described as dependent on a prior natural physiological stimulus. Its purpose is defined by the condition for which it is approved.

---

Q: How quickly should I expect Erectol Plus to start working?

According to the official pharmacokinetics data, the highest concentration of the drug in the bloodstream is typically reached within 30 to 120 minutes after administration. The median time reported for this to occur is about one hour. This timeframe may vary among individuals.

---

Q: What is the typical duration of effects after taking Erectol Plus?

The drug has an average half-life of approximately 4 hours, which is the time it takes for half of the active substance to be eliminated from the body. Studies indicate that the drug's effect on blood pressure is generally not noted 8 hours after administration.

---

Q: Is there a maximum number of times Erectol Plus can be used in one week?

Regulatory guidance for the Erectile Dysfunction indication defines the use of the medicine as once per day. This means the use is generally limited to one administration per 24-hour period, based on the approved dosing frequency.

---

Q: What are the restrictions on food or drink when taking Erectol Plus?

Official product information notes that if the tablets are taken with a high-fat meal, the rate at which the drug is absorbed into the body may be slowed down. Certain items, like grapefruit products, may increase the level of the drug in the bloodstream.

---

Q: Do people with high blood pressure need to be concerned about Erectol Plus?

Official documents describe that the drug causes mild and temporary decreases in systemic blood pressure through its action on blood vessels. Therefore, caution is described when the drug is used concurrently with other medicines that also lower blood pressure.

---

Q: Why is eligibility often described differently for older men using Erectol Plus?

Official dose selection for older adults is recommended to be cautious. This is understood to be due to the possibility of reduced function in organs like the liver, kidneys, or heart within this population, which may affect how the drug is processed.

---

Q: How soon after stopping a prohibited medicine can I use Erectol Plus?

Regulatory guidelines for nitrates mandate a minimum waiting period of 24 hours after taking them before using this drug. Information on spacing for other prescription medicines is assessed and determined by a healthcare provider.

---

Q: Are there any common over-the-counter pain relievers that interact with Erectol Plus?

The official drug interaction database indicates that no specific interaction has been found between the active ingredient and the common over-the-counter pain reliever acetaminophen (Tylenol).

---

Q: Is the effect of Erectol Plus consistent every time it is used?

The effect of the drug for Erectile Dysfunction is described as dependent on a natural stimulus, and consistency can be affected by external factors. Official pharmacokinetics data confirms that taking the medicine with a high-fat meal may influence how quickly the drug is absorbed.

---

Q: Can Erectol Plus interact with herbal supplements or vitamins?

Regulatory sources advise caution regarding herbal remedies and supplements. Since these products are not tested in the same way as prescription medicines, official sources describe the importance of discussing all herbal products and supplements with a healthcare provider.

---

Q: Can Erectol Plus be used indefinitely, or is it only for short-term use?

For the Erectile Dysfunction indication, the medicine is generally used only on an as-needed, intermittent basis. For the Pulmonary Arterial Hypertension indication in adults, continuous use is described, although specific long-term constraints exist for other populations.

---

Q: Is there a generic version of Erectol Plus available?

Yes, the active ingredient, Sildenafil, is widely available as a generic medicinal preparation, according to official drug labeling information.

---

Q: How is Erectol Plus metabolized or broken down by the body?

Official product information indicates that the drug is broken down predominantly by the liver. Specifically, this process relies heavily on specific liver enzymes known as CYP3A4.

---

Q: Is there an official patient leaflet or information sheet for Erectol Plus?

Yes, official patient information sheets and specific counseling guides are made available for the drug. These documents are approved by regulatory bodies to help patients understand its use and safety constraints.

---

Q: Can Erectol Plus be split or crushed for administration?

The medicine is produced as a film-coated tablet, but it is also available as a powder for oral suspension. This provides an alternative method of ingestion for those who may have difficulty swallowing the conventional tablet form.

---

Q: Is there any difference in how Erectol Plus affects people of different ages?

Official information indicates that the drug is generally not recommended for use in children under 1 year of age. Furthermore, cautious dose selection is advised for older patients due to potential age-related changes in body function.

---

Q: What is the role of the liver in processing Erectol Plus?

The liver is the main organ responsible for breaking down the drug in the body, primarily using specific enzymes. Because of this, regulatory documents describe that a dose adjustment should be considered for individuals with severe liver impairment.

---

Q: If I take other prescription drugs, how can I find out if they interact with Erectol Plus?

Official sources emphasize the importance of informing a healthcare provider or pharmacist about all other prescription drugs being used. This is necessary because the healthcare team has access to professional resources to check for all potential drug-drug interactions.

---

Q: Does Erectol Plus impact fertility or sperm count?

Studies have examined the effect of a single dose on healthy volunteers. This evidence indicates that the drug had no statistically significant negative effect on sperm motility, count, or density.

---

Q: What kind of studies were used to approve Erectol Plus?

Official documents describe the efficacy of the drug as being assessed in randomized, placebo-controlled clinical trials (RCTs). These studies mainly focused on patient-reported outcomes related to functional capacity and hemodynamic changes.

---

Q: Are there any restrictions on strenuous activity after using Erectol Plus?

Official patient information notes that if certain symptoms, such as chest pain, dizziness, or nausea, occur during physical activity, immediate medical attention is necessary. This is a safety instruction related to the potential cardiovascular risks associated with physical activity.

---

Q: Is it normal to feel a change in heart rate after taking this medicine?

Studies indicate that the mild, transient decrease in blood pressure caused by the drug is generally insufficient to trigger a reflex increase in heart rate. Official information notes that no significant effects on heart rate have typically been observed.

---

Q: Does Erectol Plus interact with common cholesterol-lowering medicines?

The official drug interaction database indicates that no specific interaction has been found between the active ingredient and the common cholesterol-lowering medicine atorvastatin.

---

Q: Is Erectol Plus considered a scheduled or controlled substance?

Official classification from the US Drug Enforcement Administration indicates that the drug is not considered a scheduled or controlled substance. This is based on its primary therapeutic uses and risk profile.

---

Q: Why is the liquid suspension for PAH discarded after 60 days?

Regulatory guidance states that the liquid preparation, once mixed, should be discarded after 60 days. This requirement supports the medicine retaining its necessary strength and chemical stability.

---

Q: Is it necessary to discard unused or expired Erectol Plus according to local rules?

Official patient information describes that unused or expired medication should be disposed of properly according to specific local regulatory requirements. It is noted that the medicine should not be flushed down a toilet or poured into a drain.

---

Q: Does taking Erectol Plus mean I can no longer take guanylate cyclase stimulators (such as riociguat)?

Regulatory documents define the concurrent use of this medicine with guanylate cyclase stimulators, such as riociguat, as an absolute contraindication. This means the two drug types should not be taken concurrently due to the potential for severe adverse events.

Erectol Plus (Sildenafil) must be stored in strict compliance with official regulatory requirements to ensure its stability. Tablets should be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be protected from both moisture and light and should not be stored in environments where it may freeze. For all formulations, the medicine must be kept in its original container with the lid tightly closed. The product must be stored out of the sight and reach of children.

For the liquid suspension, the reconstituted (mixed) product must be discarded after 60 days. Unused or expired medication must be disposed of properly according to local regulatory requirements; it must not be flushed down a toilet or poured into a drain.